Delu Zhou, M.D., Ph.D., is a pathologist for City of Hope Chicago (formerly Cancer Treatment Centers of America [CTCA]) in Zion, Illinois. He provides pathology analyses of tumors, including leukemia and lymphoma, ensuring that patients benefit from recent technological advances. Dr. Zhou is a licensed physician and surgeon by the States of Utah, California and Illinois, and is board certified in Anatomical and Clinical Pathology by the American Board of Pathology. Working with a multidisciplinary team, Dr. Zhou uses state-of-the-art molecular and genetic techniques to identify and classify all types of cancer.

n 2018, Dr. Jianping Lin joined Cancer Treatment Centers of America (CTCA), Chicago, as a Pathologist. Board certified in anatomic pathology and clinical pathology, Dr. Lin is dedicated to advancing the diagnosis of cancer and helping each CTCA patientâs oncologist recommend comprehensive and individualized cancer treatments. Dr. Lin works with the laboratory team at the Chicago hospital to complete and review laboratory tests. These tests help the care team diagnose and stage cancer, plan treatments, monitor the disease, review treatment progress and evaluate patient health.

Bradford Tan, MD, is Chair of the CTCA Department of Pathology and Laboratory Medicine at Cancer Treatment Centers of America (CTCA) and a Pathologist at CTCA Chicago. Dr. Tan earned his medical degree from Cebu Institute of Medicine. He is accepting new patients.

Elham Abboud, MD, is Assistant Medical Director of Pathology and Laboratory Medicine at Cancer Treatment Centers of America (CTCA) and a Pathologist at CTCA Chicago. Dr. Abboud earned her medical degree from Damascus University School of Medicine. She is accepting new patients.